Canine Cognitive Dysfunction Syndrome: Supporting Senior Dog Welfare

Canine cognitive dysfunction syndrome (CDS) is a common but under-recognized welfare problem in senior dogs, comparable to Alzheimer's disease in humans.

Key Facts

CDS affects an estimated 28% of dogs aged 11-12 and over 68% of dogs aged 15-16
Symptoms include disorientation, altered sleep patterns, house soiling, and reduced interaction
CDS is significantly under-diagnosed - owners often attribute symptoms to normal aging
Selegiline (Anipryl) is FDA-approved for canine cognitive dysfunction
Dietary supplements (omega-3s, antioxidants, medium-chain triglycerides) may slow progression
Environmental modifications can maintain quality of life as cognition declines

Welfare Considerations

Canine cognitive dysfunction is a significant welfare issue that affects quality of life for millions of senior dogs globally. The condition causes distress through disorientation, disrupted sleep, and loss of learned behaviors - welfare costs that parallel human dementia. Many dogs with CDS are euthanized for behavioral changes that could be managed with appropriate diagnosis and treatment, while others live with unrecognized cognitive decline without welfare support. Early recognition and intervention can maintain quality of life and strengthen the human-animal bond through the challenging final chapter of a dog's life.

What You Can Do

Learn the early signs of CDS to identify cognitive decline before it becomes severe
Schedule senior wellness visits twice yearly from age 7 to monitor cognitive changes
Discuss selegiline and dietary supplement options with your veterinarian
Maintain consistent routines to reduce disorientation in cognitively affected dogs
Modify your home environment with night lights, ramps, and predictable layouts
Consider quality of life assessment tools to make informed decisions about care intensity